MoneyWorks4Me

Sequent Scientific informs about earnings call transcript

16 Aug 2022 Evaluate

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that it enclosed the Earnings Call Transcript pertaining to the Unaudited Financial Results for quarter ended June 30, 2022. The same is also available on the Company’s website at https://sequent.in/pdf/financial/2022- 2023/Sequent%20Science-Q1FY23-Earnings%20Call-Aug%2009-2022.pdf.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1849.50
Dr. Reddys Labs. 1212.60
Cipla 1379.45
Lupin 2119.95
Zydus Lifesciences 1166.45
View more..